Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)
China · Delayed Price · Currency is CNY 10.08
+0.92 (10.04%)
Nov 2, 2026, 3:00 PM CST
SHA:603108 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 626.77 | 1,016 | 1,207 | 1,068 | 1,007 | 1,024 |
Trading Asset Securities | 90.95 | 129.8 | 82.2 | 58 | 106.5 | 25.49 |
Cash & Short-Term Investments | 717.72 | 1,146 | 1,289 | 1,126 | 1,114 | 1,049 |
Cash Growth | -36.15% | -11.10% | 14.45% | 1.12% | 6.15% | 4.44% |
Accounts Receivable | 4,260 | 4,637 | 5,363 | 5,684 | 6,035 | 4,292 |
Other Receivables | 167.03 | 164.02 | 205.44 | 200.57 | 233.38 | 219.74 |
Receivables | 4,427 | 4,801 | 5,569 | 5,884 | 6,270 | 4,513 |
Inventory | 1,513 | 1,732 | 1,323 | 1,377 | 1,616 | 1,502 |
Other Current Assets | 894.27 | 839.11 | 1,022 | 1,006 | 819.44 | 377.59 |
Total Current Assets | 7,552 | 8,517 | 9,203 | 9,394 | 9,819 | 7,442 |
Property, Plant & Equipment | 1,023 | 1,104 | 1,129 | 1,210 | 1,157 | 1,187 |
Long-Term Investments | 1,466 | 1,468 | 1,479 | 1,211 | 1,129 | 1,130 |
Goodwill | 1,774 | 1,774 | 1,983 | 2,012 | 1,988 | 1,898 |
Other Intangible Assets | 77.48 | 70.8 | 77.33 | 76.64 | 69.46 | 67.71 |
Long-Term Accounts Receivable | - | 11.25 | 17.8 | 23.9 | 23.12 | 22.41 |
Long-Term Deferred Tax Assets | 309.3 | 316.1 | 257.48 | 234.74 | 203.33 | 135.85 |
Long-Term Deferred Charges | 133.24 | 146.93 | 153.49 | 143 | 118.14 | 117.09 |
Other Long-Term Assets | 41.17 | 9.57 | 5.64 | 4.69 | 12.3 | 16.86 |
Total Assets | 12,376 | 13,418 | 14,306 | 14,310 | 14,519 | 12,017 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,135 | 1,219 | 1,159 | 1,507 | 1,836 | 1,163 |
Accrued Expenses | 49.7 | 110.36 | 117.06 | 148.02 | 218.99 | 160.08 |
Short-Term Debt | 4,182 | 4,861 | 4,925 | 4,712 | 5,215 | 4,203 |
Current Portion of Long-Term Debt | 1,165 | 1,003 | 836.23 | 511.69 | 620.3 | 31.48 |
Current Portion of Leases | - | 198.98 | 189.19 | 264.88 | 96.9 | 65.29 |
Current Income Taxes Payable | 69.17 | 39.59 | 68.65 | 97.02 | 94.03 | 78.71 |
Current Unearned Revenue | 77.8 | 89.63 | 97.36 | 113.21 | 185.93 | 194.57 |
Other Current Liabilities | 636.07 | 157.01 | 152.4 | 174.77 | 241.52 | 285.05 |
Total Current Liabilities | 7,315 | 7,679 | 7,544 | 7,528 | 8,509 | 6,182 |
Long-Term Debt | 236.26 | 632.82 | 886.75 | 1,103 | 823.58 | 1,220 |
Long-Term Leases | 66.44 | 168.27 | 209.38 | 159.91 | 133.45 | 177.69 |
Long-Term Unearned Revenue | 9.27 | 11.02 | 14.88 | 18.25 | 24.95 | 31.36 |
Long-Term Deferred Tax Liabilities | 33.17 | 42.98 | 43.94 | 51.86 | 16.63 | 10.72 |
Other Long-Term Liabilities | 166.32 | 2.48 | 2.41 | 2.13 | 1.62 | 2.54 |
Total Liabilities | 7,827 | 8,536 | 8,701 | 8,863 | 9,509 | 7,625 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 604.6 | 603.68 | 603.64 | 597.2 | 579.54 | 579.54 |
Additional Paid-In Capital | 1,289 | 1,254 | 1,246 | 1,160 | 921.06 | 916.3 |
Retained Earnings | 1,712 | 1,885 | 2,452 | 2,456 | 2,270 | 1,852 |
Comprehensive Income & Other | -0.29 | 42.97 | 52.89 | 67.12 | 117.68 | 114.51 |
Total Common Equity | 3,605 | 3,786 | 4,355 | 4,280 | 3,888 | 3,463 |
Minority Interest | 944.4 | 1,095 | 1,250 | 1,167 | 1,121 | 929.31 |
Shareholders' Equity | 4,549 | 4,881 | 5,604 | 5,447 | 5,010 | 4,392 |
Total Liabilities & Equity | 12,376 | 13,418 | 14,306 | 14,310 | 14,519 | 12,017 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,650 | 6,864 | 7,046 | 6,751 | 6,889 | 5,698 |
Net Cash (Debt) | -4,932 | -5,719 | -5,757 | -5,625 | -5,776 | -4,649 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -7.95 | -9.49 | -9.37 | -9.67 | -9.68 | -7.83 |
Filing Date Shares Outstanding | 620.77 | 603.68 | 603.64 | 597.2 | 579.54 | 579.54 |
Total Common Shares Outstanding | 620.77 | 603.68 | 603.64 | 597.2 | 579.54 | 579.54 |
Working Capital | 236.66 | 838.4 | 1,659 | 1,866 | 1,310 | 1,260 |
Book Value Per Share | 5.81 | 6.27 | 7.21 | 7.17 | 6.71 | 5.97 |
Tangible Book Value | 1,754 | 1,942 | 2,295 | 2,192 | 1,831 | 1,497 |
Tangible Book Value Per Share | 2.83 | 3.22 | 3.80 | 3.67 | 3.16 | 2.58 |
Buildings | - | 201.09 | 198.87 | 198.87 | 117 | 117.05 |
Machinery | - | 2,771 | 2,591 | 2,478 | 2,263 | 2,073 |
Construction In Progress | - | 3.34 | 2.85 | 18.71 | 41.43 | 19.31 |